Hugh SalterChief Scientific Officer at Anocca ABSpeaker
Profile
Hugh Salter is Chief Scientific Officer at Anocca AB. He was previously CSO of Moderna Therapeutics Sweden, and prior to that was head of the AstraZeneca Translational Science Centre at the Karolinska Institutet. He has worked over many years in drug discovery in multiple indications and modalities, with an emphasis on genetics, informatics, and translational science. He was previously adjunct full professor at Uppsala University and has a PhD from Cambridge University.
Agenda Sessions
Discovery and Development of Next Generation TCR-T Cell Therapies Against Mutant KRAS for the Treatment of Advanced Pancreatic Cancer
, 11:15amView Session